CPhI Japan, P-Mec & ICSE Japan

CPHI Japan 2027, P-Mec & ICSE Japan — Explore the Future of Pharma

CPHI Japan 2027 (part of the broader CPHI portfolio) is a major, in-person pharmaceutical meeting held in Tokyo, designed to bring together suppliers and buyers across the full drug development and manufacturing ecosystem. The event is positioned as a practical, face-to-face marketplace where pharmaceutical professionals can network, learn, and conduct meaningful business.

Event dates & location

• Start date: 21 Apr 2027
• End date: 23 Apr 2027
• Venue: East Halls, Tokyo Big Sight
• City: Tokyo
• Country: Japan

Opening times (in-person)

• 21 April: 10:00–17:00
• 22 April: 10:00–17:00
• 23 April: 10:00–17:00

What this event is about (why attend)

CPHI Japan is described as “the ultimate meeting place for suppliers and buyers from the entire pharmaceutical supply chain.” With Japan presented as a market known for elite R&D quality and a highly regulated environment, the event is tailored for organizations that need partners, sourcing options, technical collaboration, and market insight in a single location.

The event’s positioning emphasizes:

• Japan’s elite R&D quality as a core draw for science-led collaboration and advanced pharma development.
• Top suppliers across Asia enabling discovery of manufacturing and supply partners aligned with regional capabilities.
• Japan’s market insights for better commercial planning and a deeper understanding of local industry expectations.
• Face-to-face business enablement through networking, talks, panels, and direct engagement on the show floor.

Event structure: show floor + talks + matchmaking

Attendees can engage through a combination of:

• Before the event (online): explore companies and products, use matchmaking to find potential business partners, and plan meetings in advance with like-minded professionals.
• At the venue (in-person): attend talks, panels, and presentations; benefit from the impact of direct, face-to-face interaction; and connect with partners under one roof at Tokyo Big Sight.
• All year round (online): build additional connections via ongoing community engagement, participate in on-demand content, and capture opportunities that extend beyond the three-day exhibition window.

Where participants can focus: “Zones” and pharma sectors

CPHI Japan highlights exhibitor coverage across multiple sectors. These sectors are organized to help visitors identify relevant suppliers and solutions efficiently, supporting faster lead qualification and more targeted sourcing conversations.

Core zones include:

• Pharma Ingredients
• Outsourcing
• Biopharma
• Pharma Machinery & Equipment
• Formulation & Packaging

Who the event is built for (audience intent)

The event is designed for pharmaceutical professionals who operate across the supply chain—people who are actively working on sourcing, procurement, technical evaluation, partnerships, and execution of drug development and manufacturing activities. It is positioned as a “bridge” into Asia’s advanced pharma ecosystem, making it relevant for organizations targeting growth, collaboration, or entry planning within Japan and broader regional markets.

The strongest fit typically comes from organizations and individuals who need to:

• Meet suppliers and buyers in a regulated, quality-driven market context.
• Compare offerings across ingredients, outsourcing services, biopharma capabilities, equipment, and formulation/packaging solutions.
• Use pre-planning and matchmaking to reduce time spent on unqualified conversations.
• Stay informed through on-site knowledge sessions that support decision-making and partnership building.

Business engagement value: “under one roof” connectivity

The event is explicitly described as a place where participants can meet Japanese customers and suppliers in one central location. This “under one roof” concept is important for companies that rely on trusted relationships, direct technical conversations, and efficient scheduling—particularly when the market demands high compliance and quality expectations.

CPHI community and how the event connects year-round

Beyond the exhibition dates, CPHI maintains a community approach combining in-person activity with digital engagement. This supports ongoing collaboration and helps participants convert show-floor discussions into longer-term partnerships. The event ecosystem includes online connectivity through CPHI Online, ongoing insights, and access to on-demand content.

Sustainability positioning

CPHI Japan also emphasizes sustainability in its approach, communicating a commitment to working toward a sustainable future through responsible event operations and industry enablement.

Relevant event identity details (useful for research and planning)

• Brand positioning: Asia’s engine for advanced drug discovery; “At the heart of Pharma.”
• Exhibition venue: Tokyo Big Sight (East Halls).
• Dates: 21–23 April 2027.
• Show hours: 10:00–17:00 each day (in-person).
• Key engagement mechanisms: pre-event discovery, matchmaking, on-site talks/panels, and year-round online community engagement.
• Exhibitor coverage areas: pharma ingredients, outsourcing, biopharma, pharma machinery & equipment, formulation & packaging.

Bottom line

For pharmaceutical and pharma-supply-chain organizations evaluating partnerships, sourcing, technical capabilities, or market opportunities, CPHI Japan 2027 provides a concentrated, three-day platform in Tokyo. With a structured event journey (pre-planning and matchmaking online, in-person talks and direct show-floor engagement, and year-round digital connectivity), the event is built to help buyers and suppliers move from discovery to discussion—often faster than relying on fragmented outreach alone.